GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have something different.

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its capabilities.

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition to the leading FreeStyle Libre continuous glucose monitor (CGM) platform, ...

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin delivery feature to predict and help prevent high and low blood sugar.

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves SmartAdjust 2.0, the next algorithm update for the Omnipod 5. The other ...

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.